Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Dare Bioscience, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 37 | 1 | 38 | +2 |
| Shares | 4.83M | 326.2K | 6.87M | +2.37M (+52.5%) |
| Value | $8.07M | $545.0K | $13.7M | +$6.22M (+82.6%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Dare Bioscience, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 1,388,562 | $2.78M | 0.01% |
| Cubist Systematic Strategies, LLC | 77,313 | $155.0K | 0.00% |
| HRT Financial LP | 48,384 | $96.0K | 0.00% |
| Two Sigma Advisers, LP | 34,400 | $69.0K | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 30,000 | $60.0K | 0.00% |
| Two Sigma Securities, LLC | 11,617 | $23.0K | 0.00% |
| Buckingham Strategic Partners | 10,000 | $20.0K | 0.00% |
| Tortoise Investment Management, LLC | 750 | $2.00K | 0.00% |
| High Net Worth Advisory Group LLC | 1,000 | $2.00K | 0.00% |
Sold out (7)
Institutions that held Dare Bioscience, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Renaissance Technologies LLC | 324,030 | $541.0K |
| Virtu Financial LLC | 93,485 | $156.0K |
| Tower Research Capital LLC (TRC) | 74,242 | $124.0K |
| Citadel Advisors LLC | 66,613 | $111.0K |
| Millennium Management LLC | 27,103 | $45.0K |
| Patriot Financial Group Insurance Agency, LLC | 400 | $1.00K |
| Rockefeller Capital Management L.P. | 200 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held Dare Bioscience, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 326,240 | $545.0K |